Oil-Dri Increases Dividends for 19th Consecutive Year
CHICAGO, June 08, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Oil-Dri Corporation of America (NYSE: ODC) today declared quarterly cash dividends of $0.28 per share of the Company’s Common Stock and $0.21 per share of the Company’s Class B Stock, an approximate 4% increase for both classes of stock.
The dividends declared will be payable on August 26, 2022 to stockholders of record at the close of business on August 12, 2022. The Company has paid cash dividends continuously since 1974. This declaration marks the nineteenth consecutive year Oil-Dri has increased dividends.
Based on the increased declared dividend and today’s closing price of $25.51, the dividend yield on Common Stock is 4.3%.
The Company expects to release earnings for its fourth quarter of fiscal 2022 after the close of the U.S. stock market on Thursday, October 13, 2022 and to host an earnings discussion via webcast on Friday, October 14, 2022. Participation details will be posted on the Events page of the Company’s website approximately one week prior to the call.
Oil-Dri Corporation of America is a leading manufacturer and supplier of specialty sorbent products for the pet care, animal health and nutrition, fluids purification, agricultural ingredients, sports field, industrial and automotive markets. Oil-Dri is vertically integrated which enables the Company to efficiently oversee every step of the process from research and development to supply chain to marketing and sales. With over 80 years of experience, the Company continues to fulfill its mission to Create Value from Sorbent Minerals. To learn more about the Company, visit oildri.com.
Category: Dividends
Contact:Leslie A. GarberManager of Investor RelationsOil-Dri Corporation of America[email protected](312) 321-1515
Source: Oil-Dri Corporation Of America
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Electra Appoints Peter Rawlins as Chief Financial Officer; Reports Second Quarter 2026 Results
- Polar Power Reports $7.9 Million in Pacific Islands Revenue as Repeat Orders Drive Expansion Across Off-Grid and Bad-Grid Power Markets
- Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Dividend, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share